Investigative and Clinical Urology

The Korean Urological Association (대한비뇨의학회)
권호 표지
DOI QR코드

DOI QR Code

The Prevalence of Benign Prostatic Hyperplasia in Elderly Men in Korea: A Community-Based Study

한국 노령층의 전립선비대증 유병률: 지역기반 연구

Park, Hyoung-Keun;Park, Hong-Zoo;Cho, Sung-Yong;Bae, Jung-Bum;Jeong, Seong-Jin;Hong, Sung-Kyu;Yoon, Cheol-Yong;Byun, Seok-Soo;Lee, Sang-Eun;Kim, Ki-Woong
박형근;박홍주;조성용;배정범;정성진;홍성규;윤철용;변석수;이상은;김기웅

  • Published : 20090900
⟨ Previous Next ⟩

Abstract

Purpose: The incidence of benign prostatic hyperplasia (BPH) is increasing in Korea. However, there are few reports about the prevalence of BPH in elderly men in Korea. We report the prevalence of BPH in elderly men through a community-based study. Materials and Methods: We collected data from the Korean Longitudinal Study on Health and Aging (KLoSHA), which was designed as a population-based, prospective study in populations aged>65 years living in Seongnam, Korea. We selected 301 male participants by random sampling. The selected participants were interviewed with the International Prostate Symptom Score (IPSS) questionnaire and were evaluated by physical examination, blood tests, and transrectal ultrasound. The number of analyzed subjects was 236. The definition of BPH was a combination of moderate (8-19) to severe (>19) IPSS and prostate enlargement (>30 g on transrectal ultrasound). Results: The prevalence of BPH was 40% overall and 36% in men in their late 60s (65-69 years), 43% in men in their 70s (70-79 years), and 53% in men over 80 (${\geq}$80 years). BPH prevalence increased according to age but showed no statistically significant differences among the groups (p>0.05). Conclusions: The overall prevalence of BPH in this study was 40%, which was higher than in other previous epidemiologic studies in Korea. This study suggests an increasing tendency of BPH prevalence in Korea.

Keywords

References

  1. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984;132:474-9 https://doi.org/10.1016/S0022-5347(17)49698-4
  2. Garraway WM, Collins GN, Lee RJ. High prevalence of benign prostatic hypertrophy in the community. Lancet 1991;338:469-71 https://doi.org/10.1016/0140-6736(91)90543-X
  3. Lee ES, Yoo KY, Kim Y, Shin Y, Lee C. Prevalence of lower urinary tract symptoms in Korean men in a community-based study. Eur Urol 1998;33:17-21 https://doi.org/10.1159/000019529
  4. Chung TG, Chung J, Lee MS, Ahn H. Prevalence of benign prostatic hyperplasia in Jeong-Eup Area: community-based study. Korean J Urol 1999;40:52-8
  5. Rhew HY, Koo JH, Cho SS, Kang JS, Lee CK, Kim JC, et al. The prevalence of BPH in Busan city over age 40. Korean J Urol 2001;42:223-7
  6. KIm KI, Chang HJ, Cho YS, Youn TJ, Chung WY, Chae IH, et al. Current status and characteristics of hypertension control in community resident elderly Korean people: data from a Korean longitudinal study on health and aging (KLoSHa study). Hypertens Res 2008;31:97-105 https://doi.org/10.1291/hypres.31.97
  7. Barry MJ, Fowler FJ Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992;148:1549-57 https://doi.org/10.1016/S0022-5347(17)36966-5
  8. Bosch JL, Kranse R, van Mastrigt R, Schroder FH. Reasons for the weak correlation between prostate volume and urethral resistance parameters in patients with prostatism. J Urol 1995;153:689-93 https://doi.org/10.1016/S0022-5347(01)67687-0
  9. Blanker MH, Groeneveld FP, Prins A, Bernsen RM, Bohnen AM, Bosch JL. Strong effects of definition and nonresponse bias on prevalence rates of clinical benign prostatic hyperplasia: the Krimpen study of male urogenital tract problems and general health status. BJU Int 2000;85:665-71
  10. Sarma AV, Wei JT, Jacobson DJ, Dunn RL, Roberts RO, Girman CJ, et al. Comparison of lower urinary tract symptom severity and associated bother between community-dwelling black and white men: the Olmsted County Study of Urinary Symptoms and Health Status and the Flint Men's Health Study. Urology 2003;61:1086-91 https://doi.org/10.1016/S0090-4295(03)00154-7
  11. Cho KS, Jo MK, Lim D, Son H, Park SK, Yoo KY, et al. Epidemiologic survey using International Prostate Symptom Score (I-PSS) of lower urinary tract symptoms (LUTS) in elderly men above 40 years old in Seoul area. Korean J Urol 2001;42:840-8

Cited by

  1. Nitric oxide synthase 2 gene polymorphisms are associated with prostatic volume in Korean men with benign prostatic hyperplasia vol.12, pp.5, 2010, https://doi.org/10.1038/aja.2010.37
  2. The Prevalence of Urologic Disease in Young Men Based on a Review of Korean Military Conscription Examination Results vol.29, pp.3, 2009, https://doi.org/10.5534/kja.2011.29.3.218
  3. 전립선비대증 초음파 영상에서 GLCM을 이용한 컴퓨터보조진단의 영상분석 vol.15, pp.3, 2009, https://doi.org/10.5392/jkca.2015.15.03.184
  4. Association between Insulin Resistance and Benign Prostatic Hyperplasia in Healthy Middle-aged Korean Men vol.15, pp.4, 2009, https://doi.org/10.15384/kjhp.2015.15.4.202
  5. Antiproliferative Effects of New Dimeric Ellagitannin from Cornus alba in Prostate Cancer Cells Including Apoptosis-Related S-Phase Arrest vol.21, pp.2, 2016, https://doi.org/10.3390/molecules21020137
  6. 전립선 조직검사 사전정보교육이 전립선비대증 환자의 불안, 우울 및 수면의 질에 미치는 효과 vol.23, pp.1, 2009, https://doi.org/10.22705/jkashcn.2016.23.1.045
  7. Pharmacokinetics and safety profiles of tadalafil/tamsulosin HCl fixed-dose combination capsule under fasted and fed condition in healthy volunteers vol.24, pp.4, 2009, https://doi.org/10.12793/tcp.2016.24.4.175
  8. 척추마취 전립선절제술환자의 음악요법효과에 대한 융합연구 vol.8, pp.1, 2009, https://doi.org/10.15207/jkcs.2017.8.1.097
  9. 일개 상급전문종합병원 전립샘비대증 환자들의 삶의 질 영향 요인 vol.23, pp.3, 2009, https://doi.org/10.22650/jkcnr.2017.23.3.332
  10. 전립선 비대증에 대한 뜸치료의 효과 : 체계적 문헌고찰과 메타분석 vol.39, pp.3, 2018, https://doi.org/10.22246/jikm.2018.39.3.372
  11. The Prevalence of Benign Prostate Hyperplasia in Korea: Using National Health Insurance Service Data vol.43, pp.3, 2018, https://doi.org/10.21032/jhis.2018.43.3.208
  12. The Benign Prostatic Hyperplasia Incidence Rate in Korea: Using National Health Insurance Service Data vol.43, pp.3, 2009, https://doi.org/10.21032/jhis.2018.43.3.217
  13. Early Experiences of a Minimal Invasive Intra-Prostatic Implant, Prostatic Urethral Lift for Benign Prostatic Hyperplasia Treatment in Korea vol.14, pp.3, 2009, https://doi.org/10.14777/uti.2019.14.3.80
  14. Effectiveness and safety of electroacupuncture and its cotreatment with electronic moxibustion in the treatment of patients with moderate benign prostatic hyperplasia using alpha blocker : Study prot vol.99, pp.15, 2020, https://doi.org/10.1097/md.0000000000019678
  15. Association of elderly age and chronic illnesses: Role of gender as a risk factor vol.9, pp.3, 2009, https://doi.org/10.4103/jfmpc.jfmpc_1060_19
  16. Effects of poloxamer‐based thermo‐sensitive sol–gel agent on urethral stricture after transurethral resection of the prostate for benign prostatic hyperplasia: a multicentre, single vol.125, pp.1, 2009, https://doi.org/10.1111/bju.14902
  17. 전립선비대증에 대한 추나요법의 효과: 체계적 문헌 고찰 vol.15, pp.1, 2009, https://doi.org/10.30581/jkcmm.2020.15.1.65
  18. Open simple prostatectomy and robotic simple prostatectomy for large benign prostatic hyperplasia: Comparison of safety and efficacy vol.9, pp.2, 2009, https://doi.org/10.1016/j.prnil.2020.11.004